Mild to Moderate Plaque Psoriasis Clinical Trial
This is a Phase 1 clinical study for adults 18 years and older with mild to moderate Psoriasis plaques. The study will test a new medication called SFA002 to see how safe and effective it is at different dosages. What to Expect Participants will be randomly assigned to one of two groups that will receive […]
Chronic Sinus Inflammation and Nasal Polyps Clinical Trial
This is a Phase 3 clinical study for adults 18 years and older with Chronic Rhinosinusitis (long-term sinus inflammation) and Nasal Polyps that hasn’t responded well to prior treatment with systemic corticosteroids (SCS) or when those treatments aren’t suitable. The study will test a new injectable medication called amlitelimab to see how safe and […]
Moderate-to-Severe Eczema Clinical Trial
This is a Phase 3 clinical study for people 12 years and older with moderate to severe atopic dermatitis (eczema) that hasn’t responded well to prescription creams or when those treatments aren’t suitable. The study will test a new injectable medication called amlitelimab to see how safe and effective it is compared to a placebo. […]
